JMD Multi-allele genetic controls for warfarin sensitivity and thrombophilia
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robetorye, R. S.
Right arrow Articles by Elenitoba-Johnson, K. S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robetorye, R. S.
Right arrow Articles by Elenitoba-Johnson, K. S. J.
JMD 2002, Vol. 4, No. 3
Copyright © 2002 American Society for Investigative Pathology & Association for Molecular Pathology

Microarray Analysis of B-Cell Lymphoma Cell Lines with the t(14;18)

Ryan S. Robetorye*, Sandra D. Bohling{dagger}, John W. Morgan{ddagger}, G. Chris Fillmore*, Megan S. Lim*{dagger} and Kojo S. J. Elenitoba-Johnson*{dagger}

From the Department of Pathology * and Associated Regional and University Pathologists (ARUP) Institute for Clinical and Experimental Pathology, {dagger} University of Utah Health Sciences Center, Salt Lake City, Utah; and the Department of Pathology, {ddagger} Roger Williams Hospital, Providence, Rhode Island

The t(14;18) is the most common genetic alteration in follicular lymphoma, and is detectable in a subset of diffuse large B-cell lymphomas (DLBCL), resulting in over-expression of the anti-apoptotic protein BCL-2. Although the t(14;18)-induced over-expression of BCL-2 is an important step in lymphomagenesis, this aberration alone is not sufficient to produce malignant lymphoma. Further analysis of these tumors is needed to identify additional genes that might be involved in the genesis of follicular lymphoma and progression to DLBCL. To address this issue, we analyzed the gene expression profiles of four t(14;18)-positive cell lines and two t(11;14)-positive mantle-cell lymphoma cell lines using cDNA microarrays containing 4364 genes, and compared them to the genetic profile of phenotypically purified B-cells obtained from hyperplastic tonsils. A total of 137 genes were differentially expressed by approximately twofold or more in the t(14;18) cell lines relative to tonsillar B-cells. 68 genes were up-regulated, 69 genes were down-regulated, and approximately 20% of the differentially regulated genes had no known function. The up-regulated genes included a number of genes involved in the promotion of cellular proliferation and survival, as well as cell metabolism. Down-regulated genes included mediators of cell adhesion and negative regulators of cell activation and growth. Hierarchical clustering analysis separated the t(14;18) and mantle-cell lines into distinct groups based on their gene expression profiles. We confirmed the differential expression of approximately 80% of selected up- and down-regulated genes identified by microarray analysis by quantitative real-time fluorescence reverse trancriptase polymerase chain reaction (RT-PCR) analysis and/or immunoblotting. This study demonstrates the utility of cDNA microarray analysis for the assessment of global transcriptional changes that characterize t(14;18)-positive cell lines, and also for the identification of novel genes that could potentially contribute to the genesis and progression of non-Hodgkin’s lymphomas with this translocation.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
D. LeBrun, T. Baetz, C. Foster, P. Farmer, R. Sidhu, H. Guo, K. Harrison, R. Somogyi, L. D. Greller, and H. Feilotter
Predicting Outcome in Follicular Lymphoma by Using Interactive Gene Pairs
Clin. Cancer Res., January 15, 2008; 14(2): 478 - 487.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Gulmann, V. Espina, E. Petricoin III, D. L. Longo, M. Santi, T. Knutsen, M. Raffeld, E. S. Jaffe, L. A. Liotta, and A. L. Feldman
Proteomic Analysis of Apoptotic Pathways Reveals Prognostic Factors in Follicular Lymphoma
Clin. Cancer Res., August 15, 2005; 11(16): 5847 - 5855.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
G. J. Vanasse, R. K. Winn, S. Rodov, A. W. Zieske, J. T. Li, J. C. Tupper, J. Tang, E. W. Raines, M. A. Peters, K. Y. Yeung, et al.
Bcl-2 Overexpression Leads to Increases in Suppressor of Cytokine Signaling-3 Expression in B Cells and De novo Follicular Lymphoma
Mol. Cancer Res., November 1, 2004; 2(11): 620 - 631.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
J. A. Schumacher, S. D. Jenson, K. S. J. Elenitoba-Johnson, and M. S. Lim
Utility of Linearly Amplified RNA for RT-PCR Detection of Chromosomal Translocations: Validation Using the t(2;5)(p23;q35) NPM-ALK Chromosomal Translocation
J. Mol. Diagn., February 1, 2004; 6(1): 16 - 21.
[Abstract] [Full Text]


Home page
Mol. Pathol.Home page
S D Jenson, R S Robetorye, S D Bohling, J A Schumacher, J W Morgan, M S Lim, and K S J Elenitoba-Johnson
Validation of cDNA microarray gene expression data obtained from linearly amplified RNA
Mol. Pathol., December 1, 2003; 56(6): 307 - 312.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society for Investigative Pathology and the Association for Molecular Pathology.